Scutellarin ameliorates diabetic nephropathy via TGF-1 signaling pathway
NATURAL PRODUCTS AND BIOPROSPECTING(2024)
摘要
Breviscapine, a natural flavonoid mixture derived from the traditional Chinese herb Erigeron breviscapus (Vant.) Hand-Mazz, has demonstrated a promising potential in improving diabetic nephropathy (DN). However, the specific active constituent(s) responsible for its therapeutic effects and the underlying pharmacological mechanisms remain unclear. In this study, we aimed to investigate the impact of scutellarin, a constituent of breviscapine, on streptozotocin-induced diabetic nephropathy and elucidate its pharmacological mechanism(s). Our findings demonstrate that scutellarin effectively ameliorates various features of DN in vivo, including proteinuria, glomerular expansion, mesangial matrix accumulation, renal fibrosis, and podocyte injury. Mechanistically, scutellarin appears to exert its beneficial effects through modulation of the transforming growth factor-beta 1 (TGF-beta 1) signaling pathway, as well as its interaction with the extracellular signal-regulated kinase (Erk) and Wnt/beta-catenin pathways.
更多查看译文
关键词
Scutellarin,Diabetic nephropathy,Proteinuria,Fibrosis,Podocyte injury
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要